Get the Daily Brief
Latest Biotech News
Ophthalmology—neurovascular protection and AI detection in diabetic eye disease
A team in Guangzhou reported an externally validated seven-variable nomogram to predict LDL cholesterol elevation risk in community-dwelling patients with type 2 diabetes, using routine clinical...
Immuno-oncology biology—tumor delivery, resistance, and immune microenvironment rewiring
Researchers at Mass General Brigham and the University of Cyprus published a mechanistic model suggesting antibody-drug conjugate (ADC) delivery can improve by normalizing the tumor...
Genetic and cellular mechanisms in cancer progression—RNA marks, immune evasion, and new vulnerabilities
A study in Cell Death Discovery reported that an RNA chemical tag pathway involving m6A reader YTHDF2 can promote melanoma progression by destabilizing HMOX1 mRNA and shielding tumor cells from...
Clinical and real-world healthcare evidence—therapy safety, diagnostic signals, and adoption in practice
A multicenter phase III trial found intravenous tirofiban did not outperform standard oral antiplatelet therapy for 90-day functional outcomes in an acute branch atheromatous disease-related...
Ophthalmology therapeutics—device-led gene and drug approaches
An international trial led by University of Pittsburgh scientists reported that an optogenetic gene therapy with light-projecting goggles was safe and improved visual function in selected patients...
Infectious disease and vaccines—targeted prevention and diagnostic performance
Researchers in a Science study reported gut bacteria can influence whether people develop fever after mRNA vaccination, pointing to specific microbial taxa and diet factors shaping acute...
Nephrology and diabetes complications—biomarkers, mechanisms, and perioperative risk
A new iScience study combined machine learning with clinical and preclinical experiments to show lactate is both a powerful predictor and a mechanistic driver of acute kidney injury after...
Regenerative medicine and stem cell approaches—platforms and translational signals
A study using patient-derived stem-cell teratomas reported living test-bed models for Duchenne gene editing, where both gene-corrected cell transplants and lipid nanoparticle base editing restored...
AI in drug and diagnostics pipelines—validation, explainability, and clinical governance
A hybrid deep learning and radiomics system reported it could detect subjective cognitive decline—an early preclinical Alzheimer’s stage—from routine MRI scans with nearly 89% accuracy. In cancer...
Neuroscience and neurodegeneration—tau filament structure and early biomarkers
Researchers used cryo-electron microscopy to show that tau filaments have distinguishable ordered core structures across diseases, including vacuolar tauopathy variants, and reported it is...
FDA review and KRAS-specified response concerns
FDA documents reviewed for Revolution Medicines’ Rasonque flagged new scrutiny around KRAS subgroup efficacy, according to investor-focused reporting. The disclosure added pressure on the...
Biotech IPO momentum with immune modulation focus
TRexBio, partnered with Eli Lilly, raised $116 million via an IPO to advance regulatory T-cell activation programs. The company plans to use proceeds to build its pipeline around immune tolerance...
Regulatory guidance reshapes clinical care in nephrology
A randomized Vienna trial found that pushing serum bicarbonate toward near-normal targets did not slow kidney function decline in advanced chronic kidney disease compared with a more conservative...
Clinical trial result on thyroid hot-flash safety
A pooled analysis of four randomized trials reported that elinzanetant, a dual neurokinin receptor antagonist, showed no liver toxicity or cancer signals over 52 weeks. Side effects were mostly...
Real-world delivery of amyloid therapies via community neurologists
Sutter Health’s virtual review board enabled general neurologists to safely prescribe and monitor amyloid-targeting Alzheimer’s therapies in community settings. Among reviewed patients, 77% were...
Mechanism and drug-resistance in oral cancer ferroptosis escape
New research mapped how oral squamous cell carcinoma resists cisplatin by blocking ferroptosis. The secreted protein DKK1 was implicated in maintaining SLC3A2 cystine transporter activity through...
Preclinical RNA therapy for colorectal cancer via miR-124 vesicles
Scientists engineered stem cell-derived vesicles loaded with miR-124 to target colorectal cancer in preclinical models. The treatment silenced EZH2 and weakened STAT3 signaling, leading to tumor...
Matched cohorts link residual tumor burden to survival in esophageal cancer
A real-world study of 178 esophageal cancer patients found that residual tumor burden after immunotherapy predicted survival and recurrence patterns. Residual tumor grade and post-treatment lymph...
In vivo device trial: vagus nerve stimulation for cancer-related wasting
OnVagus received approval to begin the first human trial of its noninvasive vagus nerve-stimulation device for cancer-related wasting at MD Anderson Cancer Center. The program targets cachexia...
Diagnostics and adherence: insulin safety gaps in US safety-net clinics
A cross-sectional study of 16,267 insulin-requiring adults in federally qualified health centers across 17 states found that half had dangerous blood sugar, with HbA1c above 9.0%. Use of...